Analytica

Analytica Limited is an Australian company listed on the Australian Stock Exchange.

Analytica's focus is on the product development and commercialisation of a range of medical devices.

Product Development

Analytica's major released product is the AutoStart Burette. The AutoStart Burette infusion set automatically restarts the delivery of intravenous fluid once the burette has dispensed its predetermined amount of liquid or drug. Automatic restart of the IV fluid, once the drug is dispensed can provide enormous savings in nursing time during and following a medication event, and reduces the risk of blood clots forming that may obstruct the intravenous canula.

Analytica has licensed the AutoStart Burette and other burette intellectual property to Medical Australia (Formerly BMDI Tuta) who are presently working to take these products into a number of markets worldwide and negotiate supply for some major multinationals companies. The AutoStart Burette has a TGA ARTG entry, CE-marking, and USFDA 510(k) 'approval'.

Analytica is also developing an innovative Perineometer device branded PeriCoach to assist women and their clinicians in treatment of Stress Urinary Incontinence.

Investment Information

Analytica Limited (ABN 12 006 464 866) is a Brisbane-based public company listed on the Australian Stock Exchange (ASX Code: ALT). For more information, see About Us and ASX Releases.